Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 824 results for "cadila pharmaceutical"

We're looking for buyouts in the US: Pankaj R Patel
Business Standard India

We are looking for acquistions in the US: Cadila CMD

Pankaj Patel, CMD, Cadila Healthcare (Photo: Yasin D) Ahmedabad-based pharma major Cadila Healthcare which covered a long journey from being a Rs 250-crore company in 1995 to the Rs 9,800-crore behemoth that it is today. The company feels that the ... Smart Investor, 1 day ago
We're looking for buyouts in the US: Pankaj R Patel Smart Investor, 20 hours ago

1 images for "cadila pharmaceutical"

India Infoline, 1 week ago

Cadila Pharma is poised to take the next leap: CEO Rajiv Modi

The pharma firm already has 200 brands, with three or four being in the top five in India, says Rajiv Modi, Chairman CEO, Cadila Pharmaceuticals.
 Money Control3 weeks ago Can Indian pharmafight back?  Hindu Business Line1 week ago Good news: Drugs in India just got cheaper. List inside  Times of India1 week ago PHARMA COMPANIES FACE PRICE PRESSURE IN US MARKET  IPA Newspack.com2 weeks ago
[x]  
People Matters

ZYDUS CADILA GETS USFDA NOD FOR DIABETES DRUG

The pharmaceutical company Zydus Cadila has secured the final approval from the US Food and Drug Administration (USFDA) to sell its anti-diabetic Glyburide tablets in the US market. The drug will be marketed in strengths of 1.25, 2.5 and 5 mg. It ...
 Pharmacy Choice1 week ago Crisil rings warning bell for pharma on US slowdown  Economic Times1 week ago Prashant Sharma of Zydus Cadila promoted to a new role  People Matters3 weeks ago FDA nod for Zydus arm’s drug  Business Line1 month ago
[x]  
India Infoline

CADILA HEALTHCARE : Q4 net rises 11 percent

Global pharmaceutical company Cadila Healthcare on Friday posted a 11 percent increase in its net profit at Rs 388.7 crore for the fourth quarter ended March as compared to Rs.350.4 crore in the year-ago period, on account of robust sales. Total ...
 4 Traders1 week ago Cadila Healthcare Q4 net rises 11 percent  Prokerala1 week ago Cadila Healthcare Ltd 13 May 2016  India Infoline1 week ago
[x]  

Gujarat State TB Association, Sparsh with Cadila Pharma organise medical camps

Awareness was raised on tuberculosis where more than 300 villagers underwent health checkups and were given consultations Cadila Pharmaceuticals in association with Gujarat State Tuberculosis Association and Sparsh Hospital recently organised a ...
 Financial Express1 month ago

WHO Slaps Cadila With Letter Over GMP Violations, Data Integrity Issues

Shortly after receiving an FDA warning letter for major quality deficiencies, Indian drugmaker Cadila Pharmaceuticals was slammed for data integrity issues and GMP violations by the World Health Organization. The inspection — involving the ...
 FDA News1 month ago Cadila Pharma initiates awareness campaigns to observe World TBDay  CPhI.cn1 month ago Cadila Pharmaceuticals initiates awareness campaigns across Gujarat to observe World TB Day  PharmaBiz2 months ago Cadila Pharmaceuticals Ltd initiates awareness campaigns to observe World TB (Tuberculosis) Day -  Pocket News Alert.com2 months ago

Moberg Pharma signs development and licensing agreement with Cadila Pharmaceuticals for BUPI

Swedish pharmaceutical company Moberg Pharma AB (OMX: MOB) announced on Tuesday that it has entered into a development and license agreement with Cadila Pharmaceuticals Limited, a large healthcare manufacturing group in India, for BUPI, a novel ...
 Bloomberg2 months ago Moberg Pharma AB Interim Report January - March 2016  Yahoo! Finance UK and Ireland2 weeks ago MOBERG PHARMA AB : Interim report January - March 2016  4 Traders2 weeks ago Moberg Pharma partners with Cadila Pharmaceuticals for late-stage development and commercialisation of BUPI for oral mucositis  Bloomberg2 months ago
[x]  

Crisil raises red flag on impact of US slowdown; pharma stocks end on a mixed note

The BSE Healthcare index opened lower at 15,531.27 points as against its previous close of 15,540.06 points. It hit a high and a low of 15,593.73 and 15,444.71 points respectively before closing at 15,563.49 points, up by 0.15%. Pharma stocks ...
 India Infoline1 week ago

Zydus Cadila gains on receiving final approval from the USFDA for Glyburide Tablets

SENSEX 25463.09 327.13 1.27% NIFTY 7803.65 96.75 1.22% Industry: Medical/Healthcare Company Cadila Healthcare Ltd Cadila Healthcare is currently trading at Rs. 335.20, up by 1.75 points or 0.52% from its previous closing of ...
 Finalaya.com1 week ago Cadila Healthcare plans to raise Rs 18,500 crore  Press Trust of India3 weeks ago Cadila Healthcare plans to raise funds through securities  The Hindu3 weeks ago Cadila to Seek Investors' Nod to Raise up to Rs 10,000 Cr  NDTV Profit1 month ago
[x]  

Patent not to affect hepatitis C drug price in India: Gilead

New Delhi, May 11 () US-based pharmaceuticals firm Gilead Sciences Inc today said prices of its hepatitis C drug Sovaldi will not be impacted by granting of patent to it by the country's patent office. Although the medicine is quoted at USD 1,000 ...
 Times of India1 week ago Patent not to impact hepatitis C drug price in India: Gilead  Times of India1 week ago Gilead's License on Hepatitis C drugs, Sofosbuvir and Ledipasvir: a Fool's Bargain  hep Coalition2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less